Unitedhealth Group Inc (UNH)
NYSE · Price as of · Nasdaq Real Time Price
- Analysts26
- Implied upside+21.8%
- Target range$313.00 to $529.00
- EPS expected$4.12 +41%
- A year ago$2.92
- Revenue expected$111.49B -1.5%
- Estimate range$3.62 to $4.56
How Congress has done in UNH
Every purchase of UNH disclosed by a member of Congress in the last 5 years, scored over the 12 months after the trade date against SPY over the same window.
| Measure | UNH | SPY |
|---|---|---|
| Median 12-month return after purchase | +3.6% | +21.8% |
| Median difference vs SPY | -17.5% | — |
| Purchases that beat SPY | 15 of 46 (33%) | — |
| Members who bought | 17 | — |
Most frequent buyers: Kevin Hern (12), Josh Gottheimer (7), Tim Moore (4), Gil Cisneros (3), Marjorie Taylor Greene (3).
These are not returns anyone actually earned. Disclosures report a dollar bracket and no share count, so every purchase is counted once and weighted equally, and sales are not matched back to the buys that opened them. 8 of the 46 purchases are disclosed as a spouse's or dependent's rather than the member's own. Purchases from the last 12 months are excluded because their window has not closed yet.
Congress trades
| Date | Member | Action | Amount | |
|---|---|---|---|---|
| 2026-07-30 | Rich McCormick | Sale | $1,001 - $15,000 | |
| 2026-07-10 | Dan Newhouse WA | Sale | $1,001 - $15,000 | |
| 2026-06-12 | Dave McCormick PA | Sale | $1,001 - $15,000 | |
| 2026-06-04 | Maria Elvira Salazar FL | Sale | $1,001 - $15,000 | |
| 2026-03-27 | Alan Armstrong | Purchase | $15,001 - $50,000 |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 144 | August 21, 2026 | View on EDGAR |
| 4 | August 13, 2026 | FORM 4 |
| 10-Q | August 10, 2026 | 10-Q |
| 4 | August 7, 2026 | FORM 4 |
| SCHEDULE 13G | August 7, 2026 | View on EDGAR |
| 144 | August 5, 2026 | View on EDGAR |
| 8-K | July 16, 2026 | 8-K |
| 4 | July 6, 2026 | FORM 4 |
Frequently asked questions
When does UNH report earnings?
Unitedhealth Group Inc (UNH) is scheduled to report quarterly results on October 27, 2026, before the open. The 23-analyst consensus is $4.12 per share on revenue of $111.49B for the quarter ending September 30, 2026, against $2.92 and $113.16B a year earlier. It has beaten the consensus EPS estimate in all four of the last four quarters.
What do analysts expect for UNH?
26 analysts cover Unitedhealth Group Inc (UNH). The consensus rating is Buy. The average price target is $475.23, in a range of $313.00 to $529.00.
Are insiders buying or selling UNH?
We have no qualifying Form 4 insider purchases or sales on record for Unitedhealth Group Inc (UNH). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Has Congress made money trading UNH?
17 members of Congress have disclosed buying UNH in the last 5 years, 46 purchases in total. Measured over the 12 months after each trade date, the median purchase returned +3.6% against +21.8% for SPY over the same windows, and 15 of the 46 (33%) beat the index. These are not returns anyone actually earned: congressional disclosures report a dollar bracket and no share count, so each purchase is counted once and weighted equally, and later sales are not matched back to the buys that opened them.
Where can I see UNH SEC filings?
Recent filings are listed on this page, newest first. The latest is a 144 filed August 21, 2026.